ArticleGenome biology2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures.
Abstract readPublished Erratum
In one paragraph
Article in Genome biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Computed tomography-based radiomics predicts prognostic and treatment-related levels of immune infiltration in the immune microenvironment of clear cell renal cell carcinoma.BMC medical imaging · 2025Article
- Tumor associated neutrophils promote prostate cancer progression by mediating neutrophil trap secretion through PSMA1- NF-κB-HIF-1α signaling axis.Frontiers in immunology · 2025Article
- Article
- Characterization of macrophages in head and neck squamous cell carcinoma and development of MRG-based risk signature.Scientific reports · 2024Article
- Integrative analysis of ferroptosis in the hypoxic microenvironment of gastric cancer unveils the immune landscape and personalized therapeutic strategies.Frontiers in oncology · 2024Article
- Identification and validation of an immune-related gene pairs signature for three urologic cancers.Aging · 2022Article
- Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.The Journal of clinical investigation · 2018Article
Corrections and comments
- Erratum for
Authors and funding
29 authors.
Yasin ŞenbabaoğluComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA. shenbaba@gmail.com.
Ron S GejmanMolecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrew G WinerUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ming LiuImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Eliezer M Van AllenDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Guillermo de VelascoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Diana MiaoDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Irina OstrovnayaDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Esther DrillDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Augustin LunaComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nils WeinholdComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
William LeeComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brandon J ManleyUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Danny N KhalilDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Samuel D KaffenbergerUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yingbei ChenDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ludmila DanilovaSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Martin H VossGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jonathan A ColemanUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Paul RussoUrology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Victor E ReuterDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Timothy A ChanDepartment of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Emily H ChengDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
David A ScheinbergMolecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Toni K ChoueiriDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
James J HsiehGenitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Chris SanderComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
A Ari HakimiComputational Biology Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA. hakimia@mskcc.org.
Funding
X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4MRECOMBINANT ANTICD33 ANTIBODY FOR AMLR01CA055349 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SCHEINBERG, DAVID A · 1991 to 2020
$6.8MImmunoediting in Human CancerF30CA200327 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI GEJMAN, RON S · 2015 to 2018
$187kNCI NIH HHS F30 CA200327NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA055349
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.